重新编程大肠杆菌中的代谢流程,以提高胆固醇素的产生
Chunlei Zhao1,2, Xiaomin Li1,2, Liang Guo1,2
1State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, 214122, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|December 25, 2023
概括
这项研究设计了微生物细胞工厂 (MCFs),通过系统地重编程代谢流量,有效地产生氏素. 经过工程改造的大肠杆菌F51菌株实现了9.2g/L的高产量.
科学领域:
- 合成生物学 合成生物学
- 代谢工程是代谢工程.
- 生物化学生产 生化生产
背景情况:
- 重编程代谢流是有效的微生物细胞工厂 (MCF) 的关键.
- 在复杂的途径中促进代谢流传输仍然是一个挑战.
- 氏素的生产需要高效的前体供应和聚合.
研究的目的:
- 开发一个高效的MCF用于chondroitin生产.
- 通过调节其大小,方向和速度,系统地重新编程代谢流量.
- 为了优化前体池和聚合,以增强冠状素生物合成.
主要方法:
- 扩大的氨化和碳化池用于前体合成 (UDP-GalNAc和UDP-GlcA).
- 利用分子门将代谢流量从细胞生长转向氏素生产.
- 采用动态和静态式适配器来微调聚合物的流速.
主要成果:
- 成功设计了一种大肠杆菌F51菌株用于氏素生产.
- 在5L生物反应器中达到9.2g/L的高度.
- 在复杂的途径中证明了代谢流量的系统调节.
结论:
- 建立了一个系统的策略来调节复杂路径中的代谢流量.
- 这种方法使得使用工程化MCF能够有效地生物合成化学物质.
- 这项研究为优化微生物生产有价值化合物的研究提供了一个框架.
更多相关视频
11:51Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence
Published on: April 27, 2018
12.0K
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
9.8K
相关概念视频
Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
